Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

Gjertsen, Marianne K., Buanes, Trond, Rosseland, Arne R., Bakka, Arne, Gladhaug, Ivar, S�reide, Odd, Eriksen, Jon A., M�ller, Mona +4 more·2001·International Journal of Cancer

DOI 10.1002/ijc.1205

Cited by (276)

Items 101–200 of 276

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
Wenhao Luo, Gang Yang, Wentao Luo, Zhe Cao, Yueze Liu, Jiangdong Qiu, Guangyu Chen, Lei You, Fangyu Zhao, Lianfang Zheng et al. · 2020 · Cancer Cell International
A Novel Cancer Testis Antigen That Is Frequently Expressed in Pancreatic, Lung, and Endometrial Cancers
Takaho Okada, Masanori Akada, Tomonobu Fujita, Takashi Iwata, Yasufumi Goto, Kenji Kido, Tsutomu Okada, Yuriko Matsuzaki, Kouichi Kobayashi, Seiki Matsuno et al. · 2006 · Clinical Cancer Research
Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral Therapy
Birgitta Åsjö, Helen Stavang, Birger Sørensen, Ingebjørg Baksaas, Jørgen Nyhus, Nina Langeland · 2002 · AIDS Research and Human Retroviruses
MHC Class I–Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer
Michael Andrew Morse, Angeles Alvarez Secord, Kimberly Blackwell, Amy C. Hobeika, Gomathinayagam Sinnathamby, Takuya Osada, Julie Hafner, Mohan Philip, Timothy M. Clay, Herbert Kim Lyerly et al. · 2011 · Clinical Cancer Research
Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
John A. Mikszta, Philippe E. Laurent · 2008 · Expert Review of Vaccines
New Techniques and Agents in the Adjuvant Therapy of Pancreatic Cancer
Michael G.T. Raraty, Conor J. Magee, Paula Ghaneh, John P. Neoptolemos · 2002 · Acta Oncologica
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
Pan, Jing, Zhang, Qi, Sei, Shizuko, Shoemaker, Robert H., Lubet, Ronald A., Wang, Yian, You, Ming · 2017 · Oncotarget
Vaccines for Pancreatic Cancer
Kevin C. Soares, Lei Zheng, Barish H. Edil, Elizabeth M. Jaffee · 2012 · The Cancer Journal
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective
Dequan Liu, Lei Liu, Xinghan Li, Shijin Wang, Guangzhen Wu, Xiangyu Che · 2024 · Vaccines
The dark side of immunotherapy: pancreatic cancer
Gianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, Silvia Brugiapaglia, Francesco Novelli, Paola Cappello · 2020 · Cancer Drug Resistance
TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy
Roberto Bei, Antonio Scardino · 2010 · BioMed Research International
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Hang Sheng Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao · 2022 · 癌症：英文版
Molecular Targeted Intervention for Pancreatic Cancer
Altaf Mohammed, Naveena B. Janakiram, Shubham Pant, Chinthalapally V. Rao · 2015 · Cancers
Vaccination of patients with solid tumours
Giorgio Parmiani, Lorenzo Pilla, Chiara Castelli, Licia Rivoltini · 2003 · Annals of Oncology
Ins and outs of clinical trials with peptide-based vaccines
B. Salit Rachel · 2002 · Frontiers in bioscience
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners
Paola Cappello, Claudia Curcio, Giorgia Mandili, Cecilia Roux, Sara Bulfamante, Francesco Novelli · 2018 · Cancers
Synthetic peptides as cancer vaccines
Roshni Sundaram, Naveen K. Dakappagari, Pravin T. P. Kaumaya · 2002 · Biopolymers
Diagnosis and treatment of cholangiocarcinoma
Kirsten Muri Boberg, Erik Schrumpf · 2004 · Current Gastroenterology Reports
Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Dutta Gupta, Akash Chaurasiya · 2021 · International Immunopharmacology
Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro
Motoki Miyazawa, Makoto Iwahashi, Toshiyasu Ojima, Masahiro Katsuda, Masaki Nakamura, Mikihito Nakamori, Kentaro Ueda, Teiji Naka, Keiji Hayata, Takeshi Iida et al. · 2011 · Cancer Letters
Rational peptide-based tumour vaccine development and T cell monitoring
Carmen Scheibenbogen, Anne Letsch, Alexander H. Schmittel, Anne-Marie Asemissen, Eckhard Thiel, Ulrich Keilholz · 2003 · Seminars in Cancer Biology
Immunotherapeutics in Development for Prostate Cancer
Andrea Lynne Harzstark, Eric Jay Small · 2009 · The Oncologist
KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials
Maria Navarro-Jiménez, Beatríz González, Núria Mulet-Margalef, Cinta Hierro, Sergio Alonso · 2025 · npj Precision Oncology
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy
Elisa R. Donnard, Paula Fontes Asprino, Bruna Corrêa, Fabiana Bettoni, Fernanda Christtanini Koyama, Fábio C. P. Navarro, Rodrigo Oliva Perez, John M. Mariadason, Oliver M. Sieber, Robert L. Strausberg et al. · 2014 · Oncotarget
Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis
Takaho Okada, Shinobu Noji, Yasufumi Goto, Takashi Iwata, Tomonobu Fujita, Tsutomu Okada, Yuriko Matsuzaki, Masataka Kuwana, Michito Hirakata, Akira Horii et al. · 2005 · International Journal of Cancer
Immune vulnerabilities of mutant KRAS in pancreatic cancer
Noah C. Cheng, Robert H. Vonderheide · 2023 · Trends in cancer
Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer
Xiaoxiao Liu, Zhang Li, Yuexiang Wang · 2021 · Advanced Biology
Biological Approaches to Therapy of Pancreatic Cancer
Han Hsi Wong, Nicholas Robert Lemoine · 2008 · Pancreatology
HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes
Marianne Gjertsen, Ingvil Sæterdal, Stein Sæbøe‐Larssen, Gustav Gaudernack · 2003 · Journal of Molecular Medicine
Wilms’ Tumor 1 (WT1)-Targeted Cancer Vaccines To Extend Survival for Patients with Pancreatic Cancer
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira, Haruo Sugiyama · 2016 · Immunotherapy
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarak Agrebi Moumni Chouari, Francesca La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola E. Annels, Adam Enver Frampton · 2023 · Cancers
Pancreatic cancer: epidemiology, genetics, and approaches to screening.
Jason A. Konner, Eileen Mary O'Reilly · 2002 · PubMed
Molecular-Targeted Agents in Pancreatic Cancer
Everardo Delforge Saad, Paulo M. Hoff · 2004 · Cancer Control
Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
Lorena Ostios-García, Julia Villamayor, Esther Garcia-Lorenzo, D. Viñal, Jaime Feliú · 2021 · World Journal of Gastroenterology
T-cell response to unique and shared antigens and vaccination of cancer patients.
Giorgio Parmiani, Marialuisa Sensi, Chiara Castelli, Licia Rivoltini, Andrea Anichini · 2002 · PubMed
The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
Fotini Poyia, Christiana Michael Neophytou, Maria Christodoulou, Panagiotis Papageorgis · 2024 · International Journal of Molecular Sciences
Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular Therapy
Tijana Martinov, Philip D. Greenberg · 2023 · Annual Review of Cancer Biology
An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer
Ralf Georg Meyer, Stephanie Korn, Patrick Micke, Kai Becker, Christoph Huber, Thomas Wölfel, Roland Buhl · 2007 · Lung Cancer
Intratumoral injection of IL‐2‐activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde‐fixed tumor vaccine in a rat intracranial brain tumor model
Eiichi Ishikawa, Koji Tsuboi, Shingo Takano, Eiji Uchimura, Tadao Nose, Tadao Ohno · 2004 · Cancer Science
Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
Chen Jiang, Guo Xiao-Zhong, Xingshun Qi · 2017 · Journal of Immunology Research
Adjuvant therapy following resection for pancreatic adenocarcinoma
Murray F. Brennan · 2004 · Surgical Oncology Clinics of North America
Recombinant KRAS G12D Protein Vaccines Elicit Significant Anti-Tumor Effects in Mouse CT26 Tumor Models
Yuhua Wan, Yan Zhang, Gengchong Wang, Patrick Malonza Mwangi, Huaman Cai, Rongxiu Li · 2020 · Frontiers in Oncology
What Is Recent in Pancreatic Cancer Immunotherapy?
Elena Niccolai, Domenico Prisco, Mario Milco D’Elios, Amedeo Amedei · 2012 · BioMed Research International
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient
Keith L. Knutson, Mary Lenora Disis · 2002 · Human Immunology
Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy
Eileena F. Giurini, Oliver G. Ralph, Sam G. Pappas, Kajal H. Gupta · 2024 · Molecular Cancer Therapeutics
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
Thomas P. Brouwer, Alexander L. Vahrmeijer, Noel F.C.C. de Miranda · 2021 · Cellular Oncology
Immunotherapy for pancreatic cancer: current concepts
Howard L. Kaufman, Joseph Di Vito, Heidi Hörig · 2002 · Hematology/Oncology Clinics of North America
The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
Jingchang Zhang, Renfeng Li, Shuai Huang · 2022 · Frontiers in Oncology
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
Pierre Dillard, Nicholas Paul Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg · 2021 · OncoImmunology
Medical treatment of pancreatic cancer
Matthias J. Löhr · 2007 · Expert Review of Anticancer Therapy
KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma
Minh T. Than, Mark H. O’Hara, Ben Z. Stanger, Kim A. Reiss · 2024 · Molecular Cancer Therapeutics
Clinical trials of vaccines for immunotherapy in pancreatic cancer
JANET M. D. PLATE · 2011 · Expert Review of Vaccines
T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
Amedeo Amedei, Elena Niccolai, Mario Milco D’Elios · 2011 · Clinical and Developmental Immunology
Development of Immunotherapy for Pancreatic Cancer
Yutaka Kawakami, Takaho Okada, Masanori Akada · 2004 · Pancreas
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas
Markus Kieler, Matthias Unseld, Daniela Bianconi, Gerald W. Prager · 2018 · Pancreas
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
Xin Zhang, Zheng Quan Xu, Xiangpeng Dai, Xiaoling Zhang, Xueju Sophie Wang · 2023 · Frontiers in Immunology
Peptide Vaccines Against Cancer
Jay A. Berzofsky, SangKon Oh, Masaki Terabe · 2005 · Cancer treatment and research
Viro-immune therapy: A new strategy for treatment of pancreatic cancer
Andrea Marie Ibrahim · 2016 · World Journal of Gastroenterology
Cleavage and polyadenylation specificity factor (CPSF)‐derived peptides can induce HLA‐A2‐restricted and tumor‐specific CTLs in the majority of gastrointestinal cancer patients
Yoshiaki Maeda, Masaaki Ito, Nanae Harashima, Tetsuya Nakatsura, Naoya Hida, Nobue Imai, Yuuji Sato, Shigeki Shichijo, Satoru Todo, Kyogo Itoh · 2002 · International Journal of Cancer
Recent advances in immunotherapy for pancreatic cancer
Jeffrey Chi, Rajvi Patel, Hasan Rehman, Shreya Prasad Goyal, M. W. Saif · 2020 · Journal of Cancer Metastasis and Treatment
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Christo Kole, Nikolaos Charalampakis, Sergios A. Tsakatikas, Maximos Frountzas, Konstantinos G Apostolou, Dimitriοs Schizas · 2022 · Dove Medical Press (Taylor and Francis Group)
Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael Peter Manns, Tetyana Yevsa · 2017 · Human Vaccines & Immunotherapeutics
The role of adjuvant therapy for pancreatic cancer
Mark Hartley, Paula Ghaneh, Robert Sutton, John P. Neoptolemos, Conor J. Magee · 2002 · Expert Opinion on Investigational Drugs
Identification of HLA-A*0201- and A*2402-Restricted Epitopes of Mucin 5AC Expressed in Advanced Pancreatic Cancer
Sadaaki Yamazoe, Hiroaki Tanaka, Takehiko Iwauchi, Mami Yoshii, Gentaro Ito, Ryosuke Amano, Nobuya Yamada, Tetsuji Sawada, Masaichi Ohira, Kosei Hirakawa · 2011 · Pancreas
Prospects for vaccine therapy for pancreatic cancer
Gustav Gaudernack · 2006 · Best Practice & Research Clinical Gastroenterology
How does the immune system attack cancer?
Michael Andrew Morse, Herbert Kim Lyerly, Timothy M. Clay, Omar Ibrahim Abdel-Wahab, Stephen Y Chui, Jennifer L. Garst, Jared Gollob, Peter M. Grossi, Matthew F. Kalady, Paul J. Mosca et al. · 2004 · Current Problems in Surgery
Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Toru Mizuguchi, Toshihiko Torigoe, Fukino Satomi, Hiroaki Shima, Goro Kutomi, Shigenori Ota, Masayuki Ishii, Hiroshi Hayashi, Sumiyo Asakura, Yoshihiko Hirohashi et al. · 2015 · Surgery Today
Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos G Apostolou, Dimitrios Schizas · 2022 · Cancer Management and Research
Toward the Goal of Personalized Therapy in Pancreatic Cancer by Targeting the Molecular Phenotype
Nelson S. Yee · 2012 · Advances in experimental medicine and biology
Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy
Mehnaaz Lomas, Winston Liauw, D. Packham, K. Williams, Anthony Dominic Kelleher, John James Zaunders, Robyn Lynne Ward · 2004 · Annals of Oncology
Molecular mechanisms of pancreatic cancer and potential targets of treatment
Ursula Aho, Xia Zhao, Matthias J. Löhr, Roland E. Andersson · 2007 · Scandinavian Journal of Gastroenterology
Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine
Dan A. Laheru, Barbara A. Biedrzycki, Elizabeth M. Jaffee · 2012 · Methods in molecular biology
Potential association factors for developing effective peptide-based cancer vaccines
Chongming Jiang, Jianrong Li, Wei jin Zhang, Zhenkun Zhuang, Geng Liu, Wei Hong, Bo Li, Xiuqing Zhang, Cheng‐Chi Chao · 2022 · Frontiers in Immunology
Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine
Dan A. Laheru, Barbara A. Biedrzycki, Amy Morck Thomas, Elizabeth M. Jaffee · 2004 · Humana Press eBooks
A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the Carriers
Shuyun Dong, Tiefeng Xu, Peng Zhao, Kristin N. Parent, Mingnan Chen · 2016 · Theranostics
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens
Morten Orebo Holmström, Mads Hald Andersen · 2020 · Cancers
Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Virna Cepero, Jose Rafael Sierra, Silvia Giordano · 2010 · Current Pharmaceutical Design
Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide
Anastasios I. Birmpilis, Chrysoula‐Evangelia Karachaliou, Pinelopi Samara, Kyriaki Ioannou, Platon Selemenakis, Ioannis V. Kostopoulos, Nadia Kavrochorianou, Hubert Kalbacher, Evangelia Livaniou, Sylva Haralambous et al. · 2019 · Cancers
Indikationen zur Pankreasbiopsie
J. L�hr, G. Kl�ppel · 2005 · Der Pathologe
Towards Defining Specific Antigens for Cutaneous Lymphomas
Stefan B. Eichmüller · 2002 · Oncology Research and Treatment
Improvement in Treatment and Outcome of Pancreatic Ductal Adenocarcinoma in North China
Yong Chen, Ji-Hui Hao, WeiDong Ma, Yong Tang, Chun-Tao Gao, Xi-Shan Hao · 2011 · Journal of Gastrointestinal Surgery
Pancreatic Cancer Fostered Immunosuppression Privileges Tumor Growth and Progression
Daniela Basso · 2014 · Journal of Clinical & Cellular Immunology
Advanced Pancreatic Cancer
Kyriakos P. Papadopoulos, William H. Sherman · 2002 · American Journal of Cancer
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kai-Li Liang, Nilofer Saba Azad · 2025 · Cancers
From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis
Hui‐Ching Wang, Wen‐Chun Hung, Li‐Tzong Chen, Mei‐Ren Pan · 2018 · International Journal of Molecular Sciences
Engineering of a self-adjuvanted iTEP-delivered CTL vaccine
Shuyun Dong, Tiefeng Xu, Peng Wang, Peng Zhao, Mingnan Chen · 2017 · Acta Pharmacologica Sinica
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
Jørgen Nyhus, Anne‐Marte Bakken Kran, Maja A. Sommerfelt, Ingebjørg Baksaas, Birger Sørensen, Dag Kvale · 2005 · Vaccine
Personalized peptide vaccines for cancer therapy: current progress and state of the art
Satoshi Wada, Erica Yada, Junya Ohtake, Tetsuro Sasada · 2017 · Expert Review of Precision Medicine and Drug Development
Current Immunotherapeutic Strategies in Pancreatic Cancer
JANET M. D. PLATE · 2007 · Surgical Oncology Clinics of North America
Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma
Theresa L. Whiteside, William E. Gooding · 2003 · Blood Cells Molecules and Diseases
Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by Nanocarriers
Saborni Chattopadhyay, Yu‐Pei Liao, Xiang Wang, André E. Nel · 2023 · Bioengineering
Immunotherapy in pancreatic cancer—an emerging role: a narrative review
Elena B. Rangelova, Helen Kaipe · 2022 · Chinese Clinical Oncology
Systemic treatment for advanced pancreatic cancer
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana · 2023 · World Journal of Gastrointestinal Oncology
Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials
Isabel Mejia, Sandhya Bodapati, Kathryn T. Chen, Begoña Díaz · 2020 · Biomedicines
Immunotherapy: Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
Lukas Perkhofer, Alica K. Beutel, Thomas Jens Ettrich · 2019 · Visceral Medicine
Effect of Flt3 ligand gene transfer in experimental pancreatic cancer
Eduard Ryschich, Gergely Huszty, Nicolas Wentzensen, Eduard Schmidt, H. P. Knaebel, Jens Encke, Angela Märten, Markus Wolfgang Büchler, Jan Schmidt · 2006 · International Journal of Colorectal Disease
Immunobiotherapy directed against mutated and aberrantly expressed gene products in pancreas cancer
JANET M. D. PLATE, Jules E. Harris · 2005 · Journal of Cellular Biochemistry
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation as Immunotherapy for Pancreatic Cancer
Yasunobu Abe, Tetsuhide Ito, Eishi Baba, Koji Nagafuji, Ken Kawabe, Ilseung Choi, Yoshiyuki Arita, Toshihiro Miyamoto, Takanori Teshima, Shuji Nakano et al. · 2009 · Pancreas
Vaccine Therapy for Pancreatic Cancer: A Battle against Deadly Cancer
Dipesh Kumar Yadav · 2014 · Journal of Cancer Science & Therapy
Identification of HLA‐A*2402‐restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer
Takehiko Iwauchi, Hiroaki Tanaka, Sadaaki Yamazoe, Masakazu Yashiro, Mami Yoshii, Naoshi Kubo, Kazuya Muguruma, Tetsuji Sawada, Masaichi Ohira, Kosei Hirakawa · 2010 · Cancer Science